-
Je něco špatně v tomto záznamu ?
Osteopontin: The Molecular Bridge between Fat and Cardiac-Renal Disorders
E. Vianello, M. Kalousová, E. Dozio, L. Tacchini, T. Zima, MM. Corsi Romanelli
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, přehledy
NLK
Free Medical Journals
od 2000
Freely Accessible Science Journals
od 2000
PubMed Central
od 2007
Europe PubMed Central
od 2007
ProQuest Central
od 2000-03-01
Open Access Digital Library
od 2000-01-01
Open Access Digital Library
od 2007-01-01
Health & Medicine (ProQuest)
od 2000-03-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
PubMed
32759639
DOI
10.3390/ijms21155568
Knihovny.cz E-zdroje
- MeSH
- inzulinová rezistence genetika MeSH
- ledviny metabolismus patologie MeSH
- lidé MeSH
- myokard metabolismus patologie MeSH
- nemoci ledvin genetika metabolismus patologie MeSH
- nemoci srdce genetika metabolismus patologie MeSH
- nitrobřišní tuk metabolismus MeSH
- obezita genetika metabolismus patologie MeSH
- osteopontin genetika metabolismus MeSH
- tuková tkáň metabolismus MeSH
- zánět genetika patologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Osteopontin (OPN) is a multifaceted matricellular protein, with well-recognized roles in both the physiological and pathological processes in the body. OPN is expressed in the main organs and cell types, in which it induces different biological actions. During physiological conditioning, OPN acts as both an intracellular protein and soluble excreted cytokine, regulating tissue remodeling and immune-infiltrate in adipose tissue the heart and the kidney. In contrast, the increased expression of OPN has been correlated with the severity of the cardiovascular and renal outcomes associated with obesity. Indeed, OPN expression is at the "cross roads" of visceral fat extension, cardiovascular diseases (CVDs) and renal disorders, in which OPN orchestrates the molecular interactions, leading to chronic low-grade inflammation. The common factor associated with OPN overexpression in adipose, cardiac and renal tissues seems attributable to the concomitant increase in visceral fat size and the increase in infiltrated OPN+ macrophages. This review underlines the current knowledge on the molecular interactions between obesity and the cardiac-renal disorders ruled by OPN.
Department of Biomedical Sciences for Health Università degli Studi di Milano 20133 Milan Italy
U O C SMEL 1 of Clinical Pathology IRCCS Policlinico San Donato 20097 San Donato Milanese Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21012287
- 003
- CZ-PrNML
- 005
- 20210507102638.0
- 007
- ta
- 008
- 210420s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijms21155568 $2 doi
- 035 __
- $a (PubMed)32759639
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Vianello, Elena $u Department of Biomedical Sciences for Health, Università degli Studi di Milano, 20133 Milan, Italy
- 245 10
- $a Osteopontin: The Molecular Bridge between Fat and Cardiac-Renal Disorders / $c E. Vianello, M. Kalousová, E. Dozio, L. Tacchini, T. Zima, MM. Corsi Romanelli
- 520 9_
- $a Osteopontin (OPN) is a multifaceted matricellular protein, with well-recognized roles in both the physiological and pathological processes in the body. OPN is expressed in the main organs and cell types, in which it induces different biological actions. During physiological conditioning, OPN acts as both an intracellular protein and soluble excreted cytokine, regulating tissue remodeling and immune-infiltrate in adipose tissue the heart and the kidney. In contrast, the increased expression of OPN has been correlated with the severity of the cardiovascular and renal outcomes associated with obesity. Indeed, OPN expression is at the "cross roads" of visceral fat extension, cardiovascular diseases (CVDs) and renal disorders, in which OPN orchestrates the molecular interactions, leading to chronic low-grade inflammation. The common factor associated with OPN overexpression in adipose, cardiac and renal tissues seems attributable to the concomitant increase in visceral fat size and the increase in infiltrated OPN+ macrophages. This review underlines the current knowledge on the molecular interactions between obesity and the cardiac-renal disorders ruled by OPN.
- 650 _2
- $a tuková tkáň $x metabolismus $7 D000273
- 650 _2
- $a nemoci srdce $x genetika $x metabolismus $x patologie $7 D006331
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a zánět $x genetika $x patologie $7 D007249
- 650 _2
- $a inzulinová rezistence $x genetika $7 D007333
- 650 _2
- $a nitrobřišní tuk $x metabolismus $7 D050152
- 650 _2
- $a ledviny $x metabolismus $x patologie $7 D007668
- 650 _2
- $a nemoci ledvin $x genetika $x metabolismus $x patologie $7 D007674
- 650 _2
- $a myokard $x metabolismus $x patologie $7 D009206
- 650 _2
- $a obezita $x genetika $x metabolismus $x patologie $7 D009765
- 650 _2
- $a osteopontin $x genetika $x metabolismus $7 D053495
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Kalousová, Marta $u Institute of Medical Biochemistry and Laboratory Diagnostic, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12108 Prague, Czech Republic
- 700 1_
- $a Dozio, Elena $u Department of Biomedical Sciences for Health, Università degli Studi di Milano, 20133 Milan, Italy
- 700 1_
- $a Tacchini, Lorenza $u Department of Biomedical Sciences for Health, Università degli Studi di Milano, 20133 Milan, Italy
- 700 1_
- $a Zima, Tomáš $u Institute of Medical Biochemistry and Laboratory Diagnostic, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12108 Prague, Czech Republic
- 700 1_
- $a Corsi Romanelli, Massimiliano Marco $u Department of Biomedical Sciences for Health, Università degli Studi di Milano, 20133 Milan, Italy $u U.O.C. SMEL-1 of Clinical Pathology, IRCCS Policlinico San Donato, 20097 San Donato Milanese, Italy
- 773 0_
- $w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 21, č. 15 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32759639 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210507102638 $b ABA008
- 999 __
- $a ok $b bmc $g 1650617 $s 1132666
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 21 $c 15 $e 20200804 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- LZP __
- $a Pubmed-20210420